Literature DB >> 20229566

A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety.

Matthew B Boxer1, Amy M Quinn, Min Shen, Ajit Jadhav, William Leister, Anton Simeonov, Douglas S Auld, Craig J Thomas.   

Abstract

Herein, we examine the potential of a nitrile-containing propionic acid moiety as an electrophile for covalent attack by the active-site cysteine residue of caspase 1. The syntheses of several cyanopropanate-containing small molecules based on the optimized peptidic scaffold of prodrug VX-765 were accomplished. These compounds were found to be potent inhibitors of caspase 1 (IC(50) values < or =1 nM). Examination of these novel small molecules against a caspase panel demonstrated an impressive degree of selectivity for caspase 1 inhibition over other caspase isozymes. Assessment of hydrolytic stability and selected ADME properties highlighted these agents as potentially useful tools for studying caspase 1 down-regulation in various settings, including in vivo analyses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229566      PMCID: PMC3062473          DOI: 10.1002/cmdc.200900531

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  23 in total

Review 1.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

Authors:  W C Earnshaw; L M Martins; S H Kaufmann
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Caspases: keys in the ignition of cell death.

Authors:  Jean-Bernard Denault; Guy S Salvesen
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

Review 3.  Recent advances in the synthesis, design and selection of cysteine protease inhibitors.

Authors:  Alejandro Alvarez Hernandez; William R Roush
Journal:  Curr Opin Chem Biol       Date:  2002-08       Impact factor: 8.822

Review 4.  Caspase inhibitors: a pharmaceutical industry perspective.

Authors:  Steven D Linton
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

5.  Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.

Authors:  Bryan T Mott; Rafaela S Ferreira; Anton Simeonov; Ajit Jadhav; Kenny Kean-Hooi Ang; William Leister; Min Shen; Julia T Silveira; Patricia S Doyle; Michelle R Arkin; James H McKerrow; James Inglese; Christopher P Austin; Craig J Thomas; Brian K Shoichet; David J Maloney
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

6.  Structure and mechanism of interleukin-1 beta converting enzyme.

Authors:  K P Wilson; J A Black; J A Thomson; E E Kim; J P Griffith; M A Navia; M A Murcko; S P Chambers; R A Aldape; S A Raybuck
Journal:  Nature       Date:  1994-07-28       Impact factor: 49.962

7.  Peptide based interleukin-1 beta converting enzyme (ICE) inhibitors: synthesis, structure activity relationships and crystallographic study of the ICE-inhibitor complex.

Authors:  Y Okamoto; H Anan; E Nakai; K Morihira; Y Yonetoku; H Kurihara; H Sakashita; Y Terai; M Takeuchi; T Shibanuma; Y Isomura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-01       Impact factor: 1.645

8.  Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate binding.

Authors:  Michael J Romanowski; Justin M Scheer; Tom O'Brien; Robert S McDowell
Journal:  Structure       Date:  2004-08       Impact factor: 5.006

9.  Peptide aldehydes and nitriles as transition state analog inhibitors of cysteine proteases.

Authors:  E Dufour; A C Storer; R Ménard
Journal:  Biochemistry       Date:  1995-07-18       Impact factor: 3.162

Review 10.  Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases.

Authors:  Fabio Martinon; Jürg Tschopp
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

View more
  26 in total

1.  Extended subsite profiling of the pyroptosis effector protein gasdermin D reveals a region recognized by inflammatory caspase-11.

Authors:  Betsaida Bibo-Verdugo; Scott J Snipas; Sonia Kolt; Marcin Poreba; Guy S Salvesen
Journal:  J Biol Chem       Date:  2020-06-18       Impact factor: 5.157

2.  Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli.

Authors:  K Schaale; K M Peters; A M Murthy; A K Fritzsche; M-D Phan; M Totsika; A A B Robertson; K B Nichols; M A Cooper; K J Stacey; G C Ulett; K Schroder; M A Schembri; M J Sweet
Journal:  Mucosal Immunol       Date:  2015-05-20       Impact factor: 7.313

3.  Photoactivated inhibition of cathepsin K in a 3D tumor model.

Authors:  Mackenzie K Herroon; Rajgopal Sharma; Erandi Rajagurubandara; Claudia Turro; Jeremy J Kodanko; Izabela Podgorski
Journal:  Biol Chem       Date:  2016-06-01       Impact factor: 3.915

Review 4.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

5.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.

Authors:  Gilad Doitsh; Nicole L K Galloway; Xin Geng; Zhiyuan Yang; Kathryn M Monroe; Orlando Zepeda; Peter W Hunt; Hiroyu Hatano; Stefanie Sowinski; Isa Muñoz-Arias; Warner C Greene
Journal:  Nature       Date:  2014-01-23       Impact factor: 49.962

Review 6.  Targeting the NLRP3 inflammasome in inflammatory diseases.

Authors:  Matthew S J Mangan; Edward J Olhava; William R Roush; H Martin Seidel; Gary D Glick; Eicke Latz
Journal:  Nat Rev Drug Discov       Date:  2018-07-20       Impact factor: 84.694

7.  Exploring the ring potential of 2,4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer's disease therapy.

Authors:  Ransford Oduro Kumi; Opeyemi S Soremekun; Abdul Rashid Issahaku; Clement Agoni; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  J Mol Model       Date:  2020-03-04       Impact factor: 1.810

8.  Inhibition of cathepsin activity in a cell-based assay by a light-activated ruthenium compound.

Authors:  Tomasz Respondek; Rajgopal Sharma; Mackenzie K Herroon; Robert N Garner; Jessica D Knoll; Eric Cueny; Claudia Turro; Izabela Podgorski; Jeremy J Kodanko
Journal:  ChemMedChem       Date:  2014-04-11       Impact factor: 3.466

9.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315

10.  Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.

Authors:  Wei Wang; Linh T T Nguyen; Christopher Burlak; Fariba Chegini; Feng Guo; Tim Chataway; Shulin Ju; Oriana S Fisher; David W Miller; Debajyoti Datta; Fang Wu; Chun-Xiang Wu; Anuradha Landeru; James A Wells; Mark R Cookson; Matthew B Boxer; Craig J Thomas; Wei Ping Gai; Dagmar Ringe; Gregory A Petsko; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.